We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
Hotopf, M. H., Lewis, G. & Normand, C. (1996a) The Treatment of Depression: Evaluation and Cost-Effectiveness. London: London School of Hygiene and Tropical Medicine.Google Scholar
Hotopf, M. H., Lewis, G. & Normand, C. (1996b) Are SSRIs a cost-effective alternative to tricyclics?British Journal of Psychiatry, 168, 404–409.CrossRefGoogle ScholarPubMed
Hotopf, M. H., Lewis, G. & Normand, C. (1997) Putting trials on trial: the costs and consequences of small trials in depression: a systematic review of methodology. Journal of Epidemiology and Community Health, in press.CrossRefGoogle Scholar
Thompson, S. G. (1994) Why sources of heterogeneity in meta-analysis should be investigated. British Medical Journal, 309, 1351–1355.CrossRefGoogle ScholarPubMed
eLetters
No eLetters have been published for this article.